Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

19.0%

8 terminated/withdrawn out of 42 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

29%

12 trials in Phase 3/4

Results Transparency

13%

3 of 24 completed trials have results

Key Signals

3 with results7 terminated

Enrollment Performance

Analytics

Phase 2

12(30.8%)

N/A

11(28.2%)

Phase 3

6(15.4%)

Phase 4

6(15.4%)

Phase 1

3(7.7%)

Early Phase 1

1(2.6%)

39Total

Phase 2(12)

N/A(11)

Phase 3(6)

Phase 4(6)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (42)

Showing 20 of 42 trials

NCT05534165Phase 3Suspended

Tecovirimat in Non-hospitalized Patients With Monkeypox

Role: collaborator

NCT06915779Completed

Long Term Follow-up of HPV Vaccine in HIV (CTN 236)

Role: collaborator

NCT02815566Phase 4Completed

Bone Health in Aging HIV Infected Women

Role: collaborator

NCT05159531Phase 4Terminated

Virtual PrEP: Rendering PrEP Delivery More Efficient

Role: collaborator

NCT03483740Not ApplicableCompleted

Psychosocial Intervention for Older HIV+ Adults With HAND

Role: collaborator

NCT05863117Not ApplicableUnknown

Syphilis and HIV Point of Care Testing (POCT) in Saskatchewan

Role: collaborator

NCT00289952Phase 2Completed

Valproic Acid and Its Effects on HIV Latent Reservoirs

Role: collaborator

NCT02660905Phase 3Completed

HIV Drug Switch Followed by HCV Therapy in HIV-HCV Co-Infection

Role: collaborator

NCT02378766Not ApplicableCompleted

Evaluation of Web-based Interventions to Support People Living With HIV in the Adoption of Health Behaviors

Role: collaborator

NCT03550352Phase 2Terminated

Cannabinoids in PLWHIV on Effective ART

Role: collaborator

NCT02503111Not ApplicableTerminated

The HPV-SAVE Study Team: HPV Screening and Vaccine Evaluation in Men Who Have Sex With Men

Role: collaborator

NCT03837015Phase 1Completed

Estrogen, Probiotics and Vaginal Health to Prevent HIV Infection in ACB Women

Role: collaborator

NCT03259698Phase 2Unknown

Optimizing the Delivery of HIV nPEP

Role: collaborator

NCT04894448Unknown

Immunogenicity of COVID-19 Vaccination in PLWH

Role: lead

NCT04702412Not ApplicableUnknown

Electronic Capture of Adherence Barriers for HIV Care

Role: collaborator

NCT02354053Phase 4Completed

Evaluation of Switching From Current cART to Triumeq With Adherence Support Will Enhance HIV Control in Vulnerable Populations

Role: collaborator

NCT04175795Not ApplicableUnknown

Effectiveness of a Personalized Health Profile on Specificity of Self-Management Goals

Role: collaborator

NCT00212888Phase 1Completed

Combination Vaccination Before HIV Treatment Interruption

Role: collaborator

NCT03988725Not ApplicableCompleted

Nonalcoholic Steatohepatitis in HIV Mono-infection: Exploring Non-invasive Methods for Diagnosis and the Therapeutic Role of Vitamin E

Role: collaborator

NCT00428285Phase 2Completed

Tolerability, Safety, & Efficacy of Argon Plasma Coagulation to Treat Anal Intraepithelial Neoplasia in HIV-Positive Men

Role: collaborator